How a pharma giant made pain sufferers spend more

By Esther Han
Updated December 30 2017 - 9:53am, first published December 7 2017 - 9:20am

Two pharma giants have been taken to the Federal Court for allegedly misleading osteoarthritis sufferers into paying 33 per cent more for a "more effective" product that offers "targeted relief", when this was not the case.

Subscribe now for unlimited access.

$0/

(min cost $0)

or signup to continue reading

See subscription options

Get the latest Ballarat news in your inbox

Sign up for our newsletter to stay up to date.

We care about the protection of your data. Read our Privacy Policy.